Hospital Txagorritxu

Vitoria-Gasteiz 01009

1 studies enrolling now · 6 studies all time

What they study most

First Line Non-Small Cell Lung Cancer, Influenza, Influenza and Other Novel Respiratory Viruses, Insomnia, Lymphoma, Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV), Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), Type 1 Diabetes Mellitus

Studies at this site

• Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ® — Recruiting now
• A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202) — Completed
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Respiratory Virus Hospitalization Study (FLU 003 Plus) — Completed
• A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes — Completed
• Respiratory Virus Outpatient Study (FLU 002 Plus) — Completed